Do human adipose stem cell-derived artificial insulin-producing cells develop tumorigenic characteristics throughout differentiation?
- PMID: 40253677
- DOI: 10.1007/s11033-025-10432-3
Do human adipose stem cell-derived artificial insulin-producing cells develop tumorigenic characteristics throughout differentiation?
Abstract
Background: Artificial insulin-producing cells (IPCs) used to treat diabetes mellitus type 1 (DMT1) are naturally hampered by their carcinogenicity. This in vitro study aimed to examine the carcinogenic potential of IPCs produced by the differentiation of human adipose tissue-derived mesenchymal stem cells (hADSCs).
Methods and results: hADSCs were transformed into IPCs by administering insulin-transferrin, selenium (ITS), and nicotinamide in a 14-day differentiation protocol. The cells were transfected with 20 μg of pure Pdx1-pIRES recombinant vector on the tenth day of differentiation. The successful transfection was confirmed by Pdx1 overexpression and GFP fluorescence activity. The differentiated cells' capacity to release insulin and glucose-dependent C-peptide was used to evaluate their functionality. Gene expression was assessed using real-time PCR. Meanwhile, protein expression was investigated using western blotting. The transfected cells exhibited fluorescence activity and Pdx1 overexpression. The differentiated IPCs were able to secrete C-peptide and insulin. The artificial IPCs showed significantly reduced Oct4 and Nanog expression. However, the differentiation process induced a noticeable elevation in tPA expression. The artificial IPCs expressed much lower c-MYC expression compared to undifferentiated hADSCs. The differentiated cells exhibited a significant elevation in Glut2, MMP-2, CD24, P16, and P21 expression.
Conclusions: The differentiation technique used in this work produced functional beta-like cells devoid of typical markers of stem cells. The synthetic IPCs displayed characteristics of newly generated β-like cells. The artificial IPCs showed no signs of expressing tumor-associated markers. The findings imply that the artificial IPC cells lack tumor characteristics in vitro.
Keywords: Artificial insulin-producing cells; Differentiation; Human adipose tissue-derived mesenchymal stem cells; Tumor.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: All protocols of the present study were approved by the research ethics committee of the Marvdasht Branch, Islamic Azad University, Marvdasht, Iran (IR.IAU.M.REC.1402.005).
Similar articles
-
Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells.Cytotherapy. 2017 Aug;19(8):937-946. doi: 10.1016/j.jcyt.2017.05.003. Epub 2017 Jun 21. Cytotherapy. 2017. PMID: 28647274
-
The Insulin-Producing Cells Generated from Rat Adipose Tissue Mesenchymal Stem Cells via Pdx1 Overexpression Activate an Immune Response both in Vitro and in Vivo.Iran J Med Sci. 2025 Feb 1;50(2):112-123. doi: 10.30476/ijms.2024.101162.3378. eCollection 2025 Feb. Iran J Med Sci. 2025. PMID: 40026296 Free PMC article.
-
Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.Gene. 2018 May 15;654:87-94. doi: 10.1016/j.gene.2018.02.008. Epub 2018 Feb 13. Gene. 2018. PMID: 29452233
-
Stem cells as a therapeutic target for diabetes.Front Biosci (Landmark Ed). 2010 Jan 1;15(2):461-77. doi: 10.2741/3630. Front Biosci (Landmark Ed). 2010. PMID: 20036830 Free PMC article. Review.
-
Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an overview.Exp Diabetes Res. 2011;2011:406182. doi: 10.1155/2011/406182. Epub 2011 Jun 16. Exp Diabetes Res. 2011. PMID: 21747828 Free PMC article. Review.
References
-
- Popoviciu MS, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S (2023) Type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine. J Pers Med- 13(3):422. https://doi.org/10.3390/jpm13030422 - DOI - PubMed - PMC
-
- Khin PP, Lee JH, Jun H-S (2023) Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm. https://doi.org/10.1177/1721727x231154152 - DOI
-
- Balboa D, Barsby T, Lithovius V, Saarimäki-Vire J, Omar-Hmeadi M, Dyachok O et al (2022) Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol 40(7):1042–1055. https://doi.org/10.1038/s41587-022-01219-z - DOI - PubMed - PMC
-
- Velazco-Cruz L, Song J, Maxwell KG, Goedegebuure MM, Augsornworawat P, Hogrebe NJ et al (2019) Acquisition of dynamic function in human stem cell-derived β cells. Stem Cell Rep 12(2):351–365. https://doi.org/10.1016/j.stemcr.2018.12.012 - DOI
-
- Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH et al (2014) Generation of functional human pancreatic β cells in vitro. Cell 159(2):428–439. https://doi.org/10.1016/j.cell.2014.09.040 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous